๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› China
Clinical trial register · China

Studies with a Chinese investigative site

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the register
Recruitment status
Phase
Lead sponsor
Sun Yat-sen University490 Fudan University472 Second Affiliated Hospital, Zhejiang University, School of Medicine404 Peking Union Medical College Hospital282 Ruijin Hospital281
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to
19052 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Serplulimab Monotherapy in Elderly Patients With NSCLC and PD-L1 TPS โ‰ฅ 50%
NCT07596121NSCLC (Non-small Cell Lung Cancer)
Tang-Du Hospital
Phase 2
60
Xi'an
2026-05-13
Recruiting
A Study of BL-ARC002 in Patients With Locally Advanced or Metastatic Solid Tumors
NCT07591155Solid Tumors
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 1
22
Tianjin
2026-05-13
Recruiting
A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer
NCT07287098Breast Neoplasms
Eli Lilly and Company
Phase 2
600
2026-05-13
Recruiting
A Study of VRT106, Combined With Camrelizumab, and Apatinib for Advanced HCC
NCT07589244HCC
Guangzhou Virotech Pharmaceutical Co., Ltd.
Phase 2/3
66
Guangzhou
2026-05-13
Active, closed
A Pharmacokinetic Study of Gecacitinib Hydrochloride Tablets in Healthy Adult Participants.
NCT07565597Healthy
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Phase 1
64
Changsha
2026-05-12
Recruiting
Laparoscopic-endoscopic Surgery Assisted Sentinel Lymph Node Navigation Surgery for Early Gastric Cancer
NCT07615374Early Gastric Cancer
Jilin University
Not applicable
36
Changchun, Chโ€™ang-chโ€™un
2026-05-12
Recruiting
Multidimensional Dysfunction in Patients With Post-Intensive Care Syndrome in China
NCT07585578Post-Intensive Care Syndrome (PICS)
Hongying Jiang, MD
Observational
800
Huaibei, Beijing, Hunan, Henan
2026-05-12
Recruiting
Start CPAP Therapy in Obstructive Sleep Apnea Patients After Atrial Fibrillation Ablation
NCT07444372Obstructive Sleep Apnea, Sleep Disorder (Disorder), Atrial Fibrillation (AF), Sleep Disordered Breathing (SDB)
Beijing Anzhen Hospital
Not applicable
658
Beijing, Fuzhou, Zhangzhou, Nanning, Langfang, Shijiazhuang, Xingtai, Harbin
2026-05-12
Recruiting
Comparison of PRESBYOND Laser Blended Vision and Conventional Monovision LASIK in Individuals With Presbyopia: A Randomized Clinical Study
NCT07512089Presbyopia, Refractive Error
Zhongshan Ophthalmic Center, Sun Yat-sen University
Not applicable
100
Guangzhou
2026-05-12
Recruiting
A Phase โ…ก/โ…ข Clinical Trial of RC148 Plus Chemotherapy as 1L Therapy for Unresectable or Metastatic Colorectal Cancer
NCT07462143Colorectal (Colon or Rectal) Cancer
RemeGen Co., Ltd.
Phase 2/3
80
Beijing, Chongqing, Fuzhou, Meizhou, Nanjing, Shijiazhuang, Zhengzhou, Wuhan
2026-05-12
Recruiting
Phase III Clinical Study of VC005 in Adult and Adolescents With Mild to Moderate Atopic Dermatitis
NCT07592585Atopic Dermatitis
Jiangsu vcare pharmaceutical technology co., LTD
Phase 3
360
Nanjing
2026-05-12
Active, closed
Effects of Digital Health Interventions on the Physical and Mental Health of Middle School Students
NCT06547567Pediatric Obesity
Peking University
Not applicable
800
Tangshan
2026-05-12
Recruiting
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
NCT07567001Obesity, Heart Failure
Novo Nordisk A/S
Phase 3
5,610
Guangzhou, Shijiazhuang, Harbin, Changsha, Baotou, Changzhou, Nanjing, Suzhou
2026-05-11
By invitation
Wearables-and Blood-based Biomarkers-incorporated Modernisation of Circadian Rhythm Disruption Management in People Living With Alzheimer's Dementia: A Stepwise Study From Digital Inclusivity, Digital Therapy, to Digital Phenotyping and Biomarker Exploration
NCT07222449Alzheimer Disease
China Medical University Hospital
Not applicable
162
2026-05-11
Recruiting
Study of Food Effects of VV913 Capsules in Chinese Healthy Volunteers
NCT07565792Healthy Volunteers
Vigonvita Life Sciences
Phase 1
12
Hefei
2026-05-11
Active, closed
Evaluate Safety, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of BCD-261 After Single Subcutaneous Injection in Healthy Chinese Volunteers
NCT07535775Healthy Adult Participants
SPH-BIOCAD (HK) Limited
Phase 1
48
Shanghai
2026-05-11
Recruiting
CGM for Insulin-Treated T2DM During Post-Discharge Transition
NCT07414277Type 2 Diabetes Mellitus (T2DM)
Shanghai 6th People's Hospital
Not applicable
160
Shanghai
2026-05-11
Recruiting
Evaluate the Safety and Efficacy of HL-1186 Tablet for Postoperative Analgesia in Abdominal Surgery
NCT07709598Postoperative Pain
Shanghai Huilun Pharmaceutical Co., Ltd.
Phase 2/3
330
Chengdu
2026-05-11
Recruiting
Safety and Efficacy of Second Infusion of FAP iCDC in End-stage Dilated Cardiomyopathy
NCT07516288Dilated Cardiomyopathy (DCM), Heart Failure
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 1
5
Hangzhou
2026-05-11
Recruiting
QLS5212 for Participants With Advanced Solid Tumors
NCT07467629Solid Tumor Cancer
Qilu Pharmaceutical Co., Ltd.
Phase 1
100
Taiyuan
2026-05-11
Recruiting
Association Between Chronic Psychological Stress and Disease Course Outcomes in Pancreatic Cancer
NCT07529626Pancreatic Tumor, Benign, Pancreatic Cancer, Adult, Pancreatic Cancer Resectable
Shanghai Zhongshan Hospital
Observational
320
Changsha, Shanghai, Xiโ€™an
2026-05-11
Recruiting
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
NCT07517263Cardiovascular Disease and Lipoprotein(a)
Novartis Pharmaceuticals
Phase 3
5,700
Beijing, Lanzhou, Foshan, Guangzhou, Harbin, Changsha, Baotou, Nanjing
2026-05-11
Recruiting
Efficacy and Safety of NB003 in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)
NCT07379047GIST - Gastrointestinal Stromal Tumor, Advanced
Ningbo Newbay Technology Development Co., Ltd
Phase 2/3
255
Hefei, Beijing, Chongqing, Fuzhou, Guangzhou, Nanning, Guiyang, Shijiazhuang
2026-05-11
Recruiting
Dose-Effect Response in Acupuncture for Functional Constipation
NCT07506122Functional Constipation (FC)
Tongji Hospital
Not applicable
72
Wuhan
2026-05-11
Recruiting
Neoadjuvant Sacituzumab Govitecan Plus Tagitanlimab for Resectable Head and Neck Squamous Cell Carcinoma
NCT07492914Resectable Head and Neck Squamous Cell Carcinoma
West China Hospital
Phase 2
30
Chengdu
2026-05-11
Not yet open
Universal STAR-T Cell Injection in R/R Autoimmune Diseases.
NCT07599280Immune Thrombocytopenia
Jian Zhu
Phase 1
6
Haidian
2026-05-11
Not yet open
RDN for Heart Failure
NCT07558902Heart Failure
Shanghai Golden Leaf MedTec Co. Ltd
Not applicable
20
Shanghai
2026-05-10
Recruiting
Feasibility and Effectiveness of Respiratory Movement Management in Lung Cancer Receiving Stereotactic Radiotherapy Using a Novel Positional Fixation Device
NCT07561567Lung Cancer, Non-Small Cell
Tianjin Medical University Cancer Institute and Hospital
Observational
50
Tianjin
2026-05-10
Recruiting
Intranasal WSK-IM05 Vaccine Plus Tislelizumab as Neoadjuvant Therapy for HPV+ OPSCC
NCT07565740HPV-positive Oropharyngeal Squamous Cell Carcinoma
West China Hospital
Phase 1
9
Chengdu
2026-05-10
Recruiting
Exploratory Clinical Study of Anti-CD19/BCMA Universal CAR-T Cell Injection for the Treatment of Refractory Autoimmune Diseases
NCT07558850Rheumatoid Arthritis, Dermatomyositis, Systemic Lupus Erythematosus, Systemic Sclerosis
The First Affiliated Hospital with Nanjing Medical University
Not applicable
72
Nanjing
2026-05-10
Recruiting
A Phase I Clinical Trial to Evaluate the Pharmacokinetic Characteristics of Ammoxetine Hydrochloride Enteric-Coated Tablets in Participants With Moderate Renal Impairment and Normal Renal Function
NCT07694869Healthy Participants, Participants With Moderate Renal Impairment
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Phase 1
16
Hefei
2026-05-10
Not yet open
Multicenter Clinical Study on Robotic-Assisted Surgical Management of Posterior Cruciate Ligament Tibial Avulsion Fractures
NCT07575256PCL - Posterior Cruciate Ligament Deficiency, Posterior Cruciate Ligament Tear, PCL - Posterior Cruciate Ligament Rupture
Beijing Tsinghua Chang Gung Hospital
Not applicable
22
Beijing
2026-05-10
Not yet open
Safety and Efficacy of JMKX000189 for Chemotherapy-Induced Peripheral Neuropathy
NCT07601386CIPN - Chemotherapy-Induced Peripheral Neuropathy
Shanghai Jeyou Pharmaceutical Co., Ltd.
Phase 1
18
Shanghai
2026-05-10
Active, closed
Iparomlimab and Tuvonralimab Injection (QL1706) Combined With DOS as Neoadjuvant Therapy for Locally Advanced Adenocarcinoma of the Stomach and Gastroesophageal Junction
NCT07776639Gastroesophageal Junction Adenocarcinoma, Gastric Adenocarcinoma
Yongxu Jia
Phase 2
34
Zhengzhou
2026-05-10
Recruiting
Multicenter Prospective Study on MRI AI Model for Midline Glioma Subtyping and Prognosis:
NCT07608003Gliomas Harboring IDH1 and/or IDH2 Mutations, Glioma Glioblastoma Multiforme, Glioma of Brainstem, Glioma, Diffuse Midline, H3K27M-mutant
Xiangya Hospital of Central South University
Observational
500
Changsha
2026-05-10
Not yet open
Active Post-Market Surveillance of Innovative Devices for Valvular Heart Disease
NCT07605624Aortic Stenosis, Aortic Regurgitation, Mitral Regurgitation, Tricuspid Regurgitation
Beijing Anzhen Hospital
Observational
5,500
Beijing
2026-05-10
Recruiting
Intratumoral Macrophage Exosomes With Mechanobiological Reprogramming for Advanced Solid Tumors
NCT07563972Advanced Solid Tumors, Neoplasm
West China Hospital
Phase 1
9
Chengdu
2026-05-10
Recruiting
Efficacy of Liposomal Bupivacaine for Transversus Abdominis Plane Block
NCT07577934Postoperative Pain, Liposomal Bupivacaine
Tianjin First Central Hospital
Not applicable
86
Tianjin
2026-05-10
Not yet open
Efficacy and Safety of Sacituzumab Tirumotecan (SKB264) in Combination With Toripalimab in Patients With Initially Unresectable Stage III NSCLC
NCT06706219Non Small Cell Lung Cancer (Stage III)
Hunan Province Tumor Hospital
Phase 2
50
Changsha
2026-05-10
Recruiting
TP04HN106 in the Treatment of Patients With Amyotrophic Lateral Sclerosis
NCT06726577Amyotrophic Lateral Sclerosis
Talengen Institute of Life Sciences, Shenzhen, P.R. China.
Phase 1/2
60
Suzhou
2026-05-10
Recruiting
Clinical Efficacy Study of Jinfeng Pill in the Treatment of Perimenopausal Syndrome
NCT07606755Perimenopausal Syndrome
Tongji Hospital
Phase 4
100
Wuhan
2026-05-10
Recruiting
tDCS for Reducing the Incidence of OEI After Cesarean Section
NCT07569783Itching Symptoms, Itching Caused by Epidural Use of Opioids
Affiliated Hospital of Nantong University
Not applicable
104
Nantong
2026-05-10
Recruiting
A Phase II Randomized Trial of Serplulimab With Second-Line Chemo/Targeted Therapy for Early Relapse Colorectal Cancer After Adjuvant Chemotherapy
NCT07604909Colorectal Cancer, Relapse
Fudan University
Phase 2
40
Shanghai
2026-05-10
Active, closed
Beta-Blockers on Neoadjuvant Immunochemotherapy for Hypertensive Patients With Gastric Cancer
NCT07622693Gastric Cancer (GC)
Nanfang Hospital, Southern Medical University
Observational
80
Guangzhou
2026-05-10
Recruiting
Evaluate the Safety and Efficacy of HL-1186 Tablet for Postoperative Analgesia in Orthopedic Surgery
NCT07699601Postoperative Pain
Shanghai Huilun Pharmaceutical Co., Ltd.
Phase 2/3
330
Changsha
2026-05-09
Recruiting
SCTB41 Combined With Chemotherapy in Advanced Squamous Non-Small Cell Lung Cancer
NCT07662395Double Blind
Sinocelltech Ltd.
Phase 2/3
410
Guangzhou
2026-05-09
Recruiting
DLL3-Targeted PET/CT in Small Cell Lung Cancer
NCT07677787PET/CT, Small Cell Lung Cancer ( SCLC ), DLL3-targeted PET/CT, Delta-like Protein 3
The First Affiliated Hospital of Xiamen University
Not applicable
20
Xiamen
2026-05-09
Recruiting
Virtual Reality Task Oriented Training on Upper Limb Function in Stroke Patients
NCT06704074Stroke
Qilu Hospital of Shandong University
Not applicable
86
Jinan
2026-05-09
Recruiting
Retrospective Analysis of Early Gastric Cancer Patients Based on Prospective Clinical Dataset
NCT07747688Early Gastric Cancer
Beijing Friendship Hospital
Observational
5,000
Beijing
2026-05-08
Recruiting
Clinical Trials of IBI3035 in Healthy Subjects
NCT07591519Healthy Person
Innovent Biologics (Suzhou) Co. Ltd.
Phase 1
144
Chongqing
2026-05-08
Recruiting
Transcutaneous Auricular Vagus Nerve Stimulation for Poor Weight-Loss Response to Lifestyle Intervention
NCT07630597Obesity & Overweight
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Not applicable
24
Nanjing
2026-05-08
Recruiting
Westlake Frequent-sampling Cohort 2
NCT07606885Health Adults, Stability of Microbiome
Westlake University
Observational
20
Hangzhou
2026-05-08
Not yet open
AI-Assisted Optimization of Online Adaptive Radiotherapy for Gastric Lymphoma
NCT07609355Lymphoma of the Mucosa Associated Lymphoid Tissue (MALT)
Sun Yat-sen University
Not applicable
25
Guangzhou
2026-05-08
Recruiting
CD19/BCMA UCAR-T for B Cell-Related Autoimmune Disease
NCT07586267Autoimmune Diseases, Systemic Lupus Erthematosus (SLE), Multi-Drug Resistant Nephrotic Syndrome, IgA Nephropathy (IgAN)
The Children's Hospital of Zhejiang University School of Medicine
Phase EARLY_PHASE1
15
Hangzhou
2026-05-08
Active, closed
Prevalence of Pelvic Venous Congestion Syndrome in Female Patients With Lower Extremity Varicose Veins and Its Impact on Postoperative Quality of Life Improvement Following Radiofrequency Ablation: A Single-Center Prospective Cohort Study๏ผˆPCSRFStudy๏ผ‰
NCT07680465Pelvic Venous Congestion Syndrome, Lower Limb Varicose Veins, Radiofrequency Ablation
Chengdu University of Traditional Chinese Medicine
Observational
300
Chengdu
2026-05-08
Recruiting
Venetoclax, Azacitidine and Liposomal Mitoxantrone for Newly Diagnosed AML
NCT07490288AML
Institute of Hematology & Blood Diseases Hospital, China
Not applicable
27
Tianjin
2026-05-08
Recruiting
Safety and Efficacy of S103 Cells in Progressive/Refractory Multiple Sclerosis
NCT07587125Multiple Sclerosis (MS) Primary Progressive, Multiple Sclerosis, Multiple Sclerosis (MS) Secondary Progressive, Refractory Multiple Sclerosis
Xijing Hospital
Phase 1
9
Xi'an
2026-05-08
Recruiting
Effect of Different Body Positions on Hypoxemia During Recovery in Patients Undergoing Painless Gastroscopy and Colonoscopy
NCT07587970Postoperative Hypoxemia
General Hospital of Ningxia Medical University
Not applicable
1,617
Yinchuan
2026-05-08
Not yet open
GAPP Induction and Concurrent Chemoradiotherapy for High-risk Locoregionally Advanced NPC.
NCT07540390Nasopharyngeal Carcinoma
Sun Yat-sen University
Phase 3
442
Guangzhou
2026-05-08
Recruiting
Dymista in Chinese Adolescents
NCT07597473Allergic Rhinitis Due to Allergens
Viatris Inc.
Phase 4
100
Beijing, Changsha, Chengdu, Dalian, Hangzhou, Nanchang, Shanghai, Taiyuan
2026-05-08
Recruiting
A Clinical Study of Cizutamig in Thyroid Eye Disease
NCT07597200Thyroid Eye Disease, TED
Candid Therapeutics
Phase 1
38
Hefei, Beijing, Fuzhou, Foshan, Guangzhou, Changsha, Wuhan, Nanchang
2026-05-08
Recruiting
VABu Conditioning in Elderly AML HSCT
NCT07583888Allogeneic Hematopoietic Stem Cell Transplantation Recipient, Acute Myeloid Leukemia (AML)
The First Affiliated Hospital of Soochow University
Phase 2/3
20
Suzhou
2026-05-07
Recruiting
A Study of VRT106 in Combination With Radiotherapy in Adult Patients With Diffuse Midline Glioma / Diffuse Intrinsic Pontine Glioma
NCT07589257Diffuse Midline Glioma, H3 K27M-Mutant, Diffuse Intrinsic Pontine Glioma
Guangzhou Virotech Pharmaceutical Co., Ltd.
Phase 2
10
Guangzhou
2026-05-07
Active, closed
Radar Sleep Monitoring in Type 1 Narcolepsy: Feasibility
NCT07654803Narcolepsy Type 1 (NT 1), Hypersomnolence Disorder
Xijing Hospital
Observational
1
Xi'an
2026-05-07
Recruiting
Clinical Study of Adebrelimab Therapy in the Perioperative Treatment of Gastric Cancer or Gastroesophageal Junction Cancer
NCT07522151Locally Advanced Gastric or Gastroesophageal Junction Cancer
Shanghai Shengdi Pharmaceutical Co., Ltd
Phase 3
874
Beijing
2026-05-07
Not yet open
24-Week Recurrence Rate of Gout Following Firsekibart Treatment
NCT07625514Gout Flare
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
264
Fuzhou, Hangzhou, Huzhou, Jinhua, Ningbo, Wenzhou
2026-05-07
Recruiting
Allogeneic CAR-T(CT0890B) in NKG2DL+ R/R AML
NCT07617285AML, Refractory/Relapse Acute Myeloid Leukemia
Peking University People's Hospital
Phase 1
27
Beijing
2026-05-07
By invitation
Left Atrial Appendage Closure With Versus Without Pulsed Field Ablation in Atrial Fibrillation Patients With Mild Symptoms and High Stroke Risk
NCT07453940ATRIAL APPENDAGE CLOSURE for ATRIAL FIBRILLATION, PFA Ablation and LAAC Procedures
Sir Run Run Shaw Hospital
Not applicable
50
Hangzhou
2026-05-07
Recruiting
Opportunistic Breast Cancer Screening Using Non-Contrast Chest CT
NCT07557654Breast Cancer
Fudan University
Observational
5,000
Shanghai
2026-05-06
Recruiting
A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies
NCT07415031Solid Tumors
Mirati Therapeutics Inc.
Phase 2
170
Beijing, Xiamen, Zhengzhou, Changsha, Nanjing, Nanchang, Shenyang, Jinan
2026-05-06
Not yet open
Taurine for the Prevention and Treatment of Radiation-induced Oral Mucositis in Patients With Nasopharyngeal Carcinoma
NCT07567742Oral Mucositis (Ulcerative) Due to Radiation, Nasopharyngeal Carcinoma (NPC)
Sun Yat-sen University
Phase 2
130
Guangzhou
2026-05-06
Recruiting
A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Diarrhea (IBS-D)
NCT07545759Irritable Bowel Syndrome, Diarrhea
Eli Lilly and Company
Phase 2
531
Binzhou, Chengdu, Guangzhou, Hangzhou, Hengyang, Huizhou, Huzhou, Meihekou
2026-05-06
Recruiting
SAfety and eFfectiveness of cathetER Ablation for Atrial Fibrillation With Intracranial Hemorrhage (SAFER-AF)
NCT07316270AF - Atrial Fibrillation, Intracranial Hemorrhage, Spontaneous
Beijing Anzhen Hospital
Not applicable
646
Hefei, Beijing, Xiamen, Harbin, Changchun, Xi'an
2026-05-06
Not yet open
Clinical Application of Vagus Nerve Stimulation Combined With Immunoregulatory T Cells in Alleviating Aromatase Inhibitor-Induced Pain
NCT07593365Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS), Breast Cancer, Pain Alleviation
Peking University People's Hospital
Not applicable
216
Beijing
2026-05-06
Recruiting
A Study To Evaluate Pharmacokinetics, Efficacy, Safety, Tolerability, And Pharmacodynamics Of Satralizumab In Pediatric Patients With Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorder (NMOSD)
NCT05199688Neuromyelitis Optica Spectrum Disorder, NMOSD
Hoffmann-La Roche
Phase 3
8
Guangzhou, Shanghai
2026-05-06
Recruiting
Artificial Intelligence Model-Guided Neoadjuvant Anti-HER2 Targeted Therapy
NCT07528716Breast Cancer
Fudan University
Phase 3
280
Shanghai
2026-05-06
By invitation
Racecadotril for Organ Injury in Sepsis Patients
NCT07454421Sepsis
Zhujiang Hospital
Phase 1/2
44
Guanzhou
2026-05-06
Recruiting
YMN-136 Vaccine for Patients With Liver Metastasis of Colorectal Cancer Progressing After Third-Line Treatment
NCT07409805Colorectal Cancer
West China Hospital
Phase 1
9
Chengdu
2026-05-06
Recruiting
Perioperative Trial With IO/TKI for Multi-stage Clear Cell Renal Cell Carcinoma
NCT07571551Clear Cell RCC
Jinling Hospital, China
Phase 2
75
Nanjing
2026-05-06
Not yet open
Drug-Drug Interaction Study of MDR-001 With Rifampin and Itraconazole in Healthy Adult Participants
NCT07550621Healthy Volunteers (HV)
MindRank AI Ltd
Phase 1
28
Changchun
2026-05-06
Recruiting
Histidine Supplementation for Antitumor Immunity in Colorectal Cancer
NCT07577505Colorectal Cancer
Jing-yuan Fang, MD, Ph. D
Not applicable
20
Shanghai
2026-05-06
Recruiting
Efficacy and Safety of Culmerciclib Plus Aromatase Inhibitors in a Response-Adapted Neoadjuvant Strategy for Highly Proliferative ER-Positive/HER2-Negative Breast Cancer
NCT07616453HR+/HER2- Early Breast Cancer
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2
45
Hangzhou
2026-05-06
Not yet open
AI-Driven Treatment Strategy vs Pola-R-CHP in Untreated LBCL
NCT07594899Large B-Cell Lymphoma (LBCL)
Ruijin Hospital
Phase 2
178
Shanghai
2026-05-06
Recruiting
A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)
NCT07549412Metastatic Colorectal Cancer
EMD Serono Research & Development Institute, Inc.
Phase 3
1,020
Guangzhou, Nanning, Wuhan, Nanjing, Chengdu, Hangzhou
2026-05-06
Recruiting
Repeated Intravenous Thrombolysis for Ischemic Stroke With Medium to Large Vessel Occlusion Presenting Within 4.5 Hours of Onset With Prourokinase
NCT07550296Acute Ischemic Stroke
General Hospital of Shenyang Military Region
Phase 2
122
Shenyang
2026-05-06
Not yet open
A Phase II Study of Sintilimab, Pegaspargase and Selinexor Followed by Radiotherapy in Newly Diagnosed Stage I/II Extranodal NK/T-Cell Lymphoma
NCT07574528NKTCL
Sun Yat-sen University
Phase 2
47
Guangzhou
2026-05-06
Recruiting
A Study of YKST02 in Participants With Primary IgA Nephropathy
NCT07498673Primary IgA Nephropathy
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase EARLY_PHASE1
12
Wuhan
2026-05-06
Not yet open
Safety and Efficacy Evaluation of Non-invasive Temporal Interference Stimulation for Blood Pressure Modulation in Patients With Mild Essential Hypertension
NCT07577323Essential Hypertension
Xuanwu Hospital, Beijing
Not applicable
60
Beijing
2026-05-06
Recruiting
AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
NCT07571005Obesity, Overweight, Obstructive Sleep Apnoea
Novo Nordisk A/S
Phase 3
300
Beijing, Nanjing, Suzhou, Zhenjiang, Huzhou
2026-05-05
Not yet open
Retlirafusp Alfa Combined With Apatinib and Nab-Paclitaxel as Second-line Treatment for Gastric or Gastroesophageal Junction Cancer
NCT07610629Gastric Adenocarcinoma
Henan Cancer Hospital
Phase 2
50
Zhengzhou
2026-05-05
Recruiting
Transcutaneous Auricular Vagus Nerve Stimulation (taVNS)Therapy for Social Anxiety Disorder
NCT07772401Social Anxiety Disorder, Social Fear
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
100
Hangzhou
2026-05-05
Recruiting
AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
NCT07571109Obesity, Overweight, Obstructive Sleep Apnoea
Novo Nordisk A/S
Phase 3
300
Beijing, Guangzhou, Shenzhen, Luoyang, Nanjing, Tianjin
2026-05-05
Recruiting
Time-of-Day of Immunotherapy Infusion in Neoadjuvant Immunochemotherapy for Thoracic ESCC
NCT07452601Esophageal Squamous Cell Carcinoma
Tang-Du Hospital
Phase 2
90
Xi'an
2026-05-05
Not yet open
The Effect of a Single Intravenous Injection of Esketamine During Cesarean Section on Postoperative Pruritus in Patients With Intrahepatic Cholestasis of Pregnancy
NCT07560722Intrahepatic Cholestasis of Pregnancy
Tianjin Medical University General Hospital
Not applicable
160
Tianjin
2026-05-05
Recruiting
A Study to Evluate Efficacy and Safety of HRS-8080 Combined With Dalpiciclib in Patients With Advanced or Metastatic Breast Cancer Resistant to Adjuvant Endocrine Therapy.
NCT07354022Locally Advanced or Metastatic Breast Cancer
Shandong Suncadia Medicine Co., Ltd.
Phase 3
912
Beijing
2026-05-05
Recruiting
A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease
NCT07483099Crohn Disease
Eli Lilly and Company
Phase 2
60
Changsha, Changzhou, Guangzhou, Hangzhou, Huizhou, Suzhou, Wenzhou, Xiamen
2026-05-04
Recruiting
A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)
NCT07513376Non-small Cell Lung Cancer
Merck Sharp & Dohme LLC
Phase 3
876
2026-05-04
Recruiting
Single vs. Dual Antiplatelet Therapy in Patients Undergoing Percutaneous Intervention With DCB-only Strategy (KONG-FREEDOM-I)
NCT07587099Coronary Heart Disease (CHD)
Gan Lijun
Not applicable
2,170
Beijing, Haikou, Harbin, Nanchang, Heze, Jinan, Jining, Liaocheng
2026-05-04
Recruiting
A Study on Tumor Budding Guiding Individualized Surgical Planning of Early-stage Oral Squamous Cell Carcinoma.
NCT02743832Carcinoma, Squamous Cell
Jinsong Hou
Not applicable
524
Guangzhou
2026-05-04
Recruiting
AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
NCT07611110Metastatic Castration-resistant Prostate Cancer
AstraZeneca
Phase 3
670
Beijing, Chengdu, Chongqing, Fuzhou, Guangzhou, Hangzhou, Jinan, Nanjing
2026-05-04
Rows per page Showing 2301–2400 of 19052
Previous 22 23 24 25 26 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site. Derived from ClinicalTrials.gov. Retrieved 23 September 2026. https://priyalifescience.com/clinical-trials-china?page=24

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →
→

Browse trials by condition

Breast Cancer (416) Advanced Solid Tumors (183) Gastric Cancer (183) Colorectal Cancer (179) Hepatocellular Carcinoma (161) Advanced Solid Tumor (159) Solid Tumor (145) Non-Small Cell Lung Cancer (144) Acute Ischemic Stroke (138) Lung Cancer (134) Pancreatic Cancer (132) Non-small Cell Lung Cancer (131) Multiple Myeloma (126) Coronary Artery Disease (111) Prostate Cancer (111)
→

Browse trials by site location

Beijing (5484) Shanghai (3827) Guangzhou (3318) Hangzhou (1812) Wuhan (1343) Chengdu (1291) Nanjing (1193) Changsha (1154) Chongqing (1056) Fuzhou (1018) Tianjin (940) Zhengzhou (921) Hefei (875) Jinan (785) Changchun (641)
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.